Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population-based study

International Journal of Cancer. Journal International Du Cancer
D VerverW J Louwman

Abstract

Melanoma of unknown primary (MUP) may have a different biology to melanoma of known primary, but clinical trials of novel therapies (e.g., immune checkpoint or BRAF/MEK inhibitors) have not reported the outcomes in this population. We therefore evaluated the overall survival (OS) among patients with MUP in the era of novel therapy. Data for stage III or IV MUP were extracted from a nationwide database for the period 2003-2016, with classification based on the eighth edition of the American Joint Committee on Cancer criteria. The population was divided into pre- (2003-2010) and post- (2011-2016) novel therapy eras. Also, OS in the post-novel era was compared between patients with stage IV MUP by whether they received novel therapy. In total, 2028 of 65,110 patients (3.1%) were diagnosed with MUP. Metastatic sites were known in 1919 of 2028 patients, and most had stage IV disease (53.8%). For patients with stage III MUP, the 5-year OS rates were 48.5% and 50.2% in the pre- and post-novel eras, respectively (p = 0.948). For those with stage IV MUP, the median OS durations were unchanged in the pre-novel era and post-novel era when novel therapy was not used (both 4 months); however, OS improved to 11 months when novel therapy was ...Continue Reading

References

Jan 1, 1963·The Journal of Pathology and Bacteriology·R SALM
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chris C LeeDonald L Morton
Jun 24, 2010·Critical Reviews in Oncology/hematology·K KamposiorasN Pavlidis
May 26, 2011·Annals of Surgical Oncology·Sebastiaan P PrensCornelis Verhoef
Oct 4, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anne C de WaalLambertus A L M Kiemeney
May 29, 2014·Annals of Surgical Oncology·Aleksandra GosPiotr Rutkowski
Oct 9, 2016·The New England Journal of Medicine·Alexander M M EggermontAlessandro Testori
Jan 5, 2017·Dermatology : International Journal for Clinical and Investigative Dermatology·Simone RiberoCaterina Longo
Apr 5, 2017·Nature Reviews. Clinical Oncology·Jason J LukeGeorgina V Long
Aug 2, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Selma UgurelClaus Garbe
Sep 12, 2017·The New England Journal of Medicine·Georgina V LongJohn M Kirkwood
Sep 12, 2017·The New England Journal of Medicine·Jeffrey WeberUNKNOWN CheckMate 238 Collaborators
Oct 14, 2017·CA: a Cancer Journal for Clinicians·Jeffrey E GershenwaldUNKNOWN for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Disc
Nov 23, 2017·American Journal of Clinical Dermatology·Elisa A RozemanChristian U Blank
Feb 6, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L SacchettoS Rosso
Mar 28, 2018·Journal of the American Academy of Dermatology·Jeffrey F ScottJeremy S Bordeaux
Apr 17, 2018·The New England Journal of Medicine·Alexander M M EggermontCaroline Robert
Sep 20, 2018·Oncoimmunology·Paolo A Ascierto, Reinhard Dummer
Oct 23, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Axel HauschildGeorgina V Long

❮ Previous
Next ❯

Citations

Aug 12, 2020·Expert Review of Anticancer Therapy·Elie Rassy, Nicholas Pavlidis
Aug 20, 2019·International Journal of Cancer. Journal International Du Cancer·Eva EllebaekMarco Donia
Sep 11, 2020·Annals of Surgical Oncology·James P De AndradeLaleh G Melstrom
Aug 20, 2019·International Journal of Cancer. Journal International Du Cancer·Danielle VerverMarieke W J Louwman
Jan 1, 2021·Critical Reviews in Oncology/hematology·Stergios BoussiosNicholas Pavlidis
Mar 29, 2021·Cancer Immunology, Immunotherapy : CII·Danielle VerverAstrid A M van der Veldt
May 3, 2021·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·E RassyN Pavlidis
Jun 24, 2021·Medicine·Yu-Ming ChuChing-Shui Huang
Mar 5, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shang LiXiao Zhu

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases
S NakagawaT Nishino
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Anne C de WaalLambertus A L M Kiemeney
© 2022 Meta ULC. All rights reserved